Left Ventricular Dysfunction
📧 Sign up to get email alerts when something new happens for Left Ventricular Dysfunction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS [Phase 4]
Phase 4 trial investigating prophylactic suppression of frequent premature ventricular complexes and its effect on left ventricular function…
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study) [Phase 3]
Phase 3 trial updating on comparing TWA and EPS tests for predicting risk of life-threatening heart rhythms in ischemic cardiomyopathy with …
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction [Phase 2]
Phase 2 trial investigating firibastat or ramipril after acute myocardial infarction to prevent left ventricular dysfunction has completed w…
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines [Phase 3]
Phase 3 trial evaluating nebivolol for cardioprotective effects during anthracycline chemotherapy in cancer patients.
-
FDA approval · 2023-01-27FDA Approved: CAPTOPRIL — Original Application (AiPing Pharmaceutical, Inc.)
The FDA approved AiPing Pharmaceutical’s Original Application for CAPTOPRIL (captopril), a generic ACE inhibitor. The approval supports indi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-02-24FDA Approved: ENALAPRIL MALEATE ORAL SOLUTION — Original Application (NorthStar RxLLC)
FDA approved NorthStar RxLLC's enalapril maleate oral solution as an original ANDA, enabling a generic version of enalapril maleate.
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918) [NA]
A completed post-approval study evaluating strategic management to improve cardiac resynchronization therapy using multi-site pacing in pati…
-
FDA approval · 2021-10-27FDA Approved: VALSARTAN — Original Application (ScieGen Pharmaceuticals, INC.)
FDA approves the original application for VALSARTAN (Valsartan) from ScieGen Pharmaceuticals as a generic angiotensin II receptor blocker. I…
-
CLINICAL_TRIALS research · 2021-08-27Clinical Trial Update: InterventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With LVAD's
A completed clinical trial evaluating the impact of a biventricular pacemaker on ventricular function in patients with LVAD support.
-
FDA approval · 2021-08-05FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for enalaprilate maleate from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., effecti…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Balloon Pump Assisted Coronary Intervention Study [NA]
The Balloon Pump Assisted Coronary Intervention Study has completed, and its results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Cardiac Safety Study in Patients With HER2 + Breast Cancer [Phase 2]
A Phase 2 cardiac safety trial in HER2-positive breast cancer evaluated left ventricular function outcomes.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Phosphorous Magnetic Resonance Spectroscopy of Heart [NA]
A completed clinical trial investigating Phosphorus Magnetic Resonance Spectroscopy of the heart in individuals with left ventricular dysfun…
-
FDA approval · 2020-04-14FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Enalapril maleate from Northstar RxLLC under an ANDA.
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: PET and Recovery Following Revascularization (PARR 2) [Phase 3]
A Phase 3 clinical trial update on PET imaging and recovery after revascularization in coronary artery disease patients with left ventricula…
-
CLINICAL_TRIALS trial_result · 2019-09-03Clinical Trial Update: A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction [Phase 2]
Phase 2 double-blind trial evaluating BAY 1142524 for efficacy and safety after acute myocardial infarction with left ventricular dysfunctio…
-
FDA approval · 2019-08-07FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approves a supplemental application for enalapril maleate by Taro Pharmaceuticals U.S.A., Inc., pertaining to an approved product (gener…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy [NA]
A completed clinical trial update examines substrate modification as an adjunct to implantable cardioverter-defibrillator therapy for patien…
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: High-dose Selenium Supplementation in Patients With Left Ventricular Assist [Phase 3]
A Phase 3 clinical trial investigating high-dose selenium supplementation in patients with left ventricular dysfunction has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation [Phase 4]
Phase 4 trial update on pharmacological reduction of functional ischemic mitral regurgitation completed.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging [Phase 2]
Phase 2 trial assessing MRI for early detection of trastuzumab-related cardiac toxicity in breast cancer patients; the study has been termin…
-
CLINICAL_TRIALS research · 2017-07-17Clinical Trial Update: Characterization of the Plasma Proteome Following Left Ventricular Assist Device Implantation
This clinical trial characterized changes in the plasma proteome after implantation of a left ventricular assist device in patients with lef…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Predicting Response to Cardiac Resynchronization Therapy in Heart Failure
This clinical trial update summarizes results from a completed study investigating predictors of response to cardiac resynchronization thera…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: PARACHUTE V PercutAneous Ventricular RestorAtion in Chronic Heart FailUre Due to Ischemic HearT DiseasE.
A terminated clinical trial update reports that the PARACHUTE V Percutaneous Ventricular Restoration System for chronic heart failure due to…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: PROTECT-PACE STUDY - The Protection of Left Ventricular Function During Right Ventricular Pacing [NA]
Update on the PROTECT-PACE trial evaluating protection of left ventricular function during right ventricular pacing; the study is completed …